Literature DB >> 30044970

RNA Binding and HEPN-Nuclease Activation Are Decoupled in CRISPR-Cas13a.

Akshay Tambe1, Alexandra East-Seletsky1, Gavin J Knott1, Jennifer A Doudna2, Mitchell R O'Connell3.   

Abstract

CRISPR-Cas13a enzymes are RNA-guided, RNA-activated RNases. Their properties have been exploited as powerful tools for RNA detection, RNA imaging, and RNA regulation. However, the relationship between target RNA binding and HEPN (higher eukaryotes and prokaryotes nucleotide binding) domain nuclease activation is poorly understood. Using sequencing experiments coupled with in vitro biochemistry, we find that Cas13a target RNA binding affinity and HEPN-nuclease activity are differentially affected by the number and the position of mismatches between the guide and the target. We identify a central binding seed for which perfect base pairing is required for target binding and a separate nuclease switch for which imperfect base pairing results in tight binding, but not HEPN-nuclease activation. These results demonstrate that the binding and cleavage activities of Cas13a are decoupled, highlighting a complex specificity landscape. Our findings underscore a need to consider the range of effects off-target recognition has on Cas13a RNA binding and cleavage behavior for RNA-targeting tool development.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  C2c2; CRISPR-Cas systems; Cas13; Cas13a; RNA biology; RNA specificity

Mesh:

Substances:

Year:  2018        PMID: 30044970      PMCID: PMC6085867          DOI: 10.1016/j.celrep.2018.06.105

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  34 in total

1.  A general framework for development and data analysis of competitive high-throughput screens for small-molecule inhibitors of protein-protein interactions by fluorescence polarization.

Authors:  Michael H A Roehrl; Julia Y Wang; Gerhard Wagner
Journal:  Biochemistry       Date:  2004-12-28       Impact factor: 3.162

2.  Cas13b Is a Type VI-B CRISPR-Associated RNA-Guided RNase Differentially Regulated by Accessory Proteins Csx27 and Csx28.

Authors:  Aaron A Smargon; David B T Cox; Neena K Pyzocha; Kaijie Zheng; Ian M Slaymaker; Jonathan S Gootenberg; Omar A Abudayyeh; Patrick Essletzbichler; Sergey Shmakov; Kira S Makarova; Eugene V Koonin; Feng Zhang
Journal:  Mol Cell       Date:  2017-01-05       Impact factor: 17.970

3.  The Molecular Architecture for RNA-Guided RNA Cleavage by Cas13a.

Authors:  Liang Liu; Xueyan Li; Jun Ma; Zongqiang Li; Lilan You; Jiuyu Wang; Min Wang; Xinzheng Zhang; Yanli Wang
Journal:  Cell       Date:  2017-07-27       Impact factor: 41.582

4.  Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6.

Authors:  Jonathan S Gootenberg; Omar O Abudayyeh; Max J Kellner; Julia Joung; James J Collins; Feng Zhang
Journal:  Science       Date:  2018-02-15       Impact factor: 47.728

5.  RISC is a 5' phosphomonoester-producing RNA endonuclease.

Authors:  Javier Martinez; Thomas Tuschl
Journal:  Genes Dev       Date:  2004-04-22       Impact factor: 11.361

6.  RNA editing with CRISPR-Cas13.

Authors:  David B T Cox; Jonathan S Gootenberg; Omar O Abudayyeh; Brian Franklin; Max J Kellner; Julia Joung; Feng Zhang
Journal:  Science       Date:  2017-10-25       Impact factor: 47.728

7.  C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector.

Authors:  Omar O Abudayyeh; Jonathan S Gootenberg; Silvana Konermann; Julia Joung; Ian M Slaymaker; David B T Cox; Sergey Shmakov; Kira S Makarova; Ekaterina Semenova; Leonid Minakhin; Konstantin Severinov; Aviv Regev; Eric S Lander; Eugene V Koonin; Feng Zhang
Journal:  Science       Date:  2016-06-02       Impact factor: 47.728

8.  Argonaute divides its RNA guide into domains with distinct functions and RNA-binding properties.

Authors:  Liang Meng Wee; C Fabián Flores-Jasso; William E Salomon; Phillip D Zamore
Journal:  Cell       Date:  2012-11-21       Impact factor: 41.582

9.  RNA targeting with CRISPR-Cas13.

Authors:  Omar O Abudayyeh; Jonathan S Gootenberg; Patrick Essletzbichler; Shuo Han; Julia Joung; Joseph J Belanto; Vanessa Verdine; David B T Cox; Max J Kellner; Aviv Regev; Eric S Lander; Daniel F Voytas; Alice Y Ting; Feng Zhang
Journal:  Nature       Date:  2017-10-04       Impact factor: 49.962

Review 10.  MicroRNAs: target recognition and regulatory functions.

Authors:  David P Bartel
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

View more
  21 in total

1.  Programmable RNA-Guided RNA Effector Proteins Built from Human Parts.

Authors:  Simone Rauch; Emily He; Michael Srienc; Huiqing Zhou; Zijie Zhang; Bryan C Dickinson
Journal:  Cell       Date:  2019-06-20       Impact factor: 41.582

2.  Optimization of specific RNA knockdown in mammalian cells with CRISPR-Cas13.

Authors:  Brandon Joseph Davis Burris; Adrian Moises Molina Vargas; Brandon J Park; Mitchell R O'Connell
Journal:  Methods       Date:  2022-08-17       Impact factor: 4.647

Review 3.  RNA-targeting CRISPR-Cas systems.

Authors:  Sam P B van Beljouw; Jasper Sanders; Alicia Rodríguez-Molina; Stan J J Brouns
Journal:  Nat Rev Microbiol       Date:  2022-09-28       Impact factor: 78.297

4.  Intact RNA structurome reveals mRNA structure-mediated regulation of miRNA cleavage in vivo.

Authors:  Minglei Yang; Hugh C Woolfenden; Yueying Zhang; Xiaofeng Fang; Qi Liu; Maria L Vigh; Jitender Cheema; Xiaofei Yang; Matthew Norris; Sha Yu; Alberto Carbonell; Peter Brodersen; Jiawei Wang; Yiliang Ding
Journal:  Nucleic Acids Res       Date:  2020-09-04       Impact factor: 16.971

5.  Structural Basis for the RNA-Guided Ribonuclease Activity of CRISPR-Cas13d.

Authors:  Cheng Zhang; Silvana Konermann; Nicholas J Brideau; Peter Lotfy; Xuebing Wu; Scott J Novick; Timothy Strutzenberg; Patrick R Griffin; Patrick D Hsu; Dmitry Lyumkis
Journal:  Cell       Date:  2018-09-20       Impact factor: 41.582

Review 6.  RNA-targeting CRISPR systems from metagenomic discovery to transcriptomic engineering.

Authors:  Aaron A Smargon; Yilan J Shi; Gene W Yeo
Journal:  Nat Cell Biol       Date:  2020-02-03       Impact factor: 28.824

7.  Programmable RNA editing with compact CRISPR-Cas13 systems from uncultivated microbes.

Authors:  Chunlong Xu; Yingsi Zhou; Qingquan Xiao; Bingbing He; Guannan Geng; Zikang Wang; Birong Cao; Xue Dong; Weiya Bai; Yifan Wang; Xiang Wang; Dongming Zhou; Tanglong Yuan; Xiaona Huo; Jinsheng Lai; Hui Yang
Journal:  Nat Methods       Date:  2021-05-03       Impact factor: 28.547

8.  Designing sensitive viral diagnostics with machine learning.

Authors:  Hayden C Metsky; Nicole L Welch; Priya P Pillai; Nicholas J Haradhvala; Laurie Rumker; Sreekar Mantena; Yibin B Zhang; David K Yang; Cheri M Ackerman; Juliane Weller; Paul C Blainey; Cameron Myhrvold; Michael Mitzenmacher; Pardis C Sabeti
Journal:  Nat Biotechnol       Date:  2022-03-03       Impact factor: 68.164

9.  CRISPR-Cas13a Inhibits HIV-1 Infection.

Authors:  Lijuan Yin; Fei Zhao; Hong Sun; Zhen Wang; Yu Huang; Weijun Zhu; Fengwen Xu; Shan Mei; Xiaoman Liu; Di Zhang; Liang Wei; Shan Cen; Siqi Hu; Chen Liang; Fei Guo
Journal:  Mol Ther Nucleic Acids       Date:  2020-06-01       Impact factor: 8.886

Review 10.  Functional Features and Current Applications of the RNA-Targeting Type VI CRISPR-Cas Systems.

Authors:  Vanja Perčulija; Jinying Lin; Bo Zhang; Songying Ouyang
Journal:  Adv Sci (Weinh)       Date:  2021-05-05       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.